Stephanie Scanlan learned about the shortages of basic chemotherapy drugs this spring in the most frightening way. Two of the three drugs typically used to treat her rare bone cancer were too scarce. She would have to go forward without them.Ms. Scanlan, 56, the manager of a busy state office in Tallahassee, Fla., had sought…
